Status:
COMPLETED
Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents
Lead Sponsor:
Arizona State University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Vaccine-Preventable Diseases
COVID-19 Pandemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
COVID-19 vaccines are available to children over six months, and these vaccines are powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have lower COVID-19 vaccination...
Detailed Description
Among children and adolescents, infection with SARS-CoV-2 (COVID-19) can lead to health complications (e.g., multisystem inflammatory syndrome, long COVID), hospitalizations, and death. COVID-19 vacci...
Eligibility Criteria
Inclusion
- self-identifies as Hispanic
- is a biological parent or a legal guardian of at least one child under 18 years old
- their child(ren) are not vaccinated against up-to-date with COVID-19 vaccine doses
- agrees to send and receive a text message and submit a photo of their child's immunization record for T3 data collection.
Exclusion
- individuals who do not meet inclusion criteria or are unable/ unwilling to provide consent.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06036134
Start Date
July 1 2024
End Date
July 30 2025
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona State University
Phoenix, Arizona, United States, 85004